Management of therapeutic unfractionated heparin in COVID‐19 patients: A retrospective cohort study

BACKGROUND: Patients hospitalized with severe acute respiratory syndrome coronavirus 2 infection are at risk for thrombotic complications necessitating use of therapeutic unfractionated heparin (UFH). Full‐dose anticoagulation limits requirements for organ support interventions in moderately ill pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Weeks, Lachelle D., Sylvester, Katelyn W., Connors, Jean M., Connell, Nathan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114028/
https://www.ncbi.nlm.nih.gov/pubmed/34013153
http://dx.doi.org/10.1002/rth2.12521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114028/
https://www.ncbi.nlm.nih.gov/pubmed/34013153
http://dx.doi.org/10.1002/rth2.12521

Ejemplares similares